Latest news

Filter News Articles

Conditions






Topics





















COVID-19 vaccination guidance for people living with multiple sclerosis (MS)

Professor Bill Carroll AM has provided advice regarding guidance for people living with multiple sclerosis (MS) and the COVID-19 vaccination.

COVID-19 vaccination guidance for people living with multiple sclerosis (MS).
Australian research projects progress with new funding

Australian MS research projects progress with new funding, thanks to our support of MSRA.

MSWA is the leading contributor to neurological research in WA and the leading state contributor to MS Research Australia (MSRA).
MSWA’s commitment to research

Did you know we are Western Australia’s leading contributor to neurological research?

Leadership update

Ros Harman has been named MSWA’s President of the Board, following George Pampacos’ recent resignation from the position.

MSWA Board Member nominated for WA Australian of the Year

MSWA Board Member Professor William Carroll AM has been nominated for the 2021 WA Australian of the Year.

MSWA Board Member Professor William Carroll AM.
Demystifying demyelinating diseases

MSWA is proud to continue funding the Perron Institute’s Demyelinating Diseases Research group and they have been active across many areas in 2020, with members working both independently and collaboratively towards shared targets.

Perron Institute Allan Kermode.
Toxicity study for neuroprotective stroke treatment

MSWA is proud to have contributed funding towards collecting data for a potential neuroprotective drug for stroke and other conditions.

Neville Knuckey and Bruno Meloni Perron Institute Lab for MSWA.
Australian Government approves PBS listing of Siponimod (Mayzent®) for secondary progressive MS

The Hon Greg Hunt MP has announced the listing of siponimod (Mayzent) for the treatment of SPMS on the PBS.

MSWA Medication update - PBS listing of Siponimod (Mayzent®) for secondary progressive MS.
Fighting the effects of Parkinson’s disease

Boxing workouts are becoming increasingly popular to help people living with Parkinson’s disease manage their symptoms.

Safer, more comfortable Customer transfers thanks to new equipment

Funds raised from last year’s MSWA Ocean Ride – Powered by RetraVision have been used to purchase approximately $50k worth of equipment to support Western Australians living with a neurological condition.

Read more